Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Douglas Matsunaga"'
Autor:
Douglas Matsunaga, Parameswaran G Sreekumar, Keijiro Ishikawa, Hiroto Terasaki, Ernesto Barron, Pinchas Cohen, Ram Kannan, David R Hinton
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0165150 (2016)
Humanin (HN) is a small mitochondrial-encoded peptide with neuroprotective properties. We have recently shown protection of retinal pigmented epithelium (RPE) cells by HN in oxidative stress; however, the effect of HN on endoplasmic reticulum (ER) st
Externí odkaz:
https://doaj.org/article/8d1f6bb2bf164a69a289aaeca1521478
Autor:
Begoña Comin-Anduix, Hooman Sazegar, Thinle Chodon, Douglas Matsunaga, Jason Jalil, Erika von Euw, Helena Escuin-Ordinas, Robert Balderas, Bartosz Chmielowski, Jesus Gomez-Navarro, Richard C Koya, Antoni Ribas
Publikováno v:
PLoS ONE, Vol 5, Iss 9, p e12711 (2010)
The effects on cell signalling networks upon blockade of cytotoxic T lymphocyte-associated antigen-4 (CTLA4) using the monoclonal antibody tremelimumab were studied in peripheral blood mononuclear cell (PBMC) samples from patients with metastatic mel
Externí odkaz:
https://doaj.org/article/d7329642d3d84e15b0ee700bc793b3d5
Autor:
Connie M Wu, Israel Ojalvo, Allen Chiang, Mirataollah Salabati, Allen C. Ho, Arunan Sivalingam, Douglas Matsunaga, Raziyeh Mahmoudzadeh, Justin Bilello, Turner D. Wibbelsman, Jason Hsu, Anthony Obeid
Publikováno v:
American Journal of Ophthalmology. 233:1-7
Purpose : To evaluate the effect of loss to follow up (LTFU) on outcomes in eyes with diabetic macular edema (DME) treated with anti-vascular endothelial growth factor (VEGF). Design : Retrospective cohort study Methods : Single-center study of 90 ey
Publikováno v:
Journal of American Association for Pediatric Ophthalmology and Strabismus. 24:253-255
A 16-year-old girl noted worsening redness and photophobia of the right eye that had previously been treated unsuccessfully with sequential courses of topical antibiotics and topical corticosteroids. Clinical examination revealed diffuse flakelike th
Autor:
Lisa C. Olmos de Koo, Jack Yi, Carmen A. Puliafito, Amir H. Kashani, Douglas Matsunaga, Hossein Ameri
Publikováno v:
Ophthalmic Surgery, Lasers and Imaging Retina. 46:796-805
BACKGROUND AND OBJECTIVE: Optical coherence tomography angiography (OCTA) is a novel, non-invasive OCT technique capable of imaging the retinal vasculature. This study aims to evaluate the retinal microvasculature in diabetic human subjects with OCTA
Publikováno v:
Ophthalmic Surgery, Lasers and Imaging Retina. 45:510-515
BACKGROUND AND OBJECTIVE: To noninvasively evaluate the retinal microvasculature in healthy human subjects with optical coherence tomography angiography (OCTA). PATIENTS AND METHODS: Cross-sectional, observational study of five healthy subjects. OCTA
Autor:
David R. Hinton, Ram Kannan, Keijiro Ishikawa, Hiroto Terasaki, Pinchas Cohen, Ernesto Barron, Douglas Matsunaga, Parameswaran G. Sreekumar
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0165150 (2016)
PLoS ONE
PLoS ONE
Humanin (HN) is a small mitochondrial-encoded peptide with neuroprotective properties. We have recently shown protection of retinal pigmented epithelium (RPE) cells by HN in oxidative stress; however, the effect of HN on endoplasmic reticulum (ER) st
Autor:
Thinle Chodon, Earl Avramis, Douglas Matsunaga, Amol . Rao, Helena Escuin-Ordinas, Deborah J.L. Wong, Kimberly Komatsubara, Mohammad Atefi, Richard C. Koya, Begoña Comin-Anduix, Antoni Ribas
Publikováno v:
Cancer immunology research, vol 2, iss 5
Histone deacetylase inhibitors (HDACi) have been reported to increase tumor antigen expression, and have been successfully tested as adjuvants for melanoma immunotherapy in mouse models. In this work, we tested the effects of a pan-HDACi on human lym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b6731a39cad510335a90407f9bc0afa
https://escholarship.org/uc/item/1gn4q8wb
https://escholarship.org/uc/item/1gn4q8wb
Autor:
Richard C. Koya, Hooman Sazegar, Antoni Ribas, Helena Escuin-Ordinas, Bartosz Chmielowski, Jason Jalil, Thinle Chodon, Begoña Comin-Anduix, Douglas Matsunaga, Stephen Mock
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 16(24)
Purpose: PLX4032 (RG7204), an oncogenic BRAF kinase inhibitor undergoing clinical evaluation, has high response rates in early clinical trials in patients with advanced BRAFV600E mutant melanoma. Combining PLX4032 with immunotherapy may allow expandi
Autor:
Thinle Chodon, Begoña Comin-Anduix, Robert Balderas, Jason Jalil, Richard C. Koya, Douglas Matsunaga, Erika von Euw, Antoni Ribas, Hooman Sazegar, Bartosz Chmielowski, Helena Escuin-Ordinas, Jesus Gomez-Navarro
Publikováno v:
PloS one, vol 5, iss 9
PLoS ONE, Vol 5, Iss 9, p e12711 (2010)
PLoS ONE
PLoS ONE, Vol 5, Iss 9, p e12711 (2010)
PLoS ONE
Author(s): Comin-Anduix, Begona; Sazegar, Hooman; Chodon, Thinle; Matsunaga, Douglas; Jalil, Jason; von Euw, Erika; Escuin-Ordinas, Helena; Balderas, Robert; Chmielowski, Bartosz; Gomez-Navarro, Jesus; Koya, Richard C; Ribas, Antoni | Abstract: Backg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b4948aea0efb0e678d0f85f43c96649
https://escholarship.org/uc/item/0sw0t455
https://escholarship.org/uc/item/0sw0t455